OCS – oculis holding ag (US:NASDAQ)
Stock Stats
News
Oculis to Present at the Stifel 2024 Healthcare Conference
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Oculis Reports Q3 2024 Financial Results and Provides Company Updates
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees [Yahoo! Finance]
Form SC 13G/A Oculis Holding AG Filed by: Pivotal bioVenture Partners Fund I, L.P.
Form 6-K Oculis Holding AG For: Nov 07
Form EFFECT Oculis Holding AG
Form 424B3 Oculis Holding AG
Form F-3 Oculis Holding AG
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.